Mariner LLC Invests $190,000 in Grail, Inc. (NASDAQ:GRAL)

Mariner LLC acquired a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 10,619 shares of the company's stock, valued at approximately $190,000.

Other large investors have also made changes to their positions in the company. FNY Investment Advisers LLC purchased a new position in Grail in the fourth quarter worth approximately $26,000. Lindbrook Capital LLC purchased a new position in Grail in the fourth quarter worth approximately $28,000. Sterling Capital Management LLC purchased a new position in shares of Grail during the fourth quarter worth $29,000. Wellington Shields Capital Management LLC purchased a new position in shares of Grail during the fourth quarter worth $33,000. Finally, New York State Common Retirement Fund purchased a new position in shares of Grail during the fourth quarter worth $59,000.

Grail Stock Up 2.2%

Shares of NASDAQ GRAL traded up $0.78 during mid-day trading on Monday, hitting $35.98. The company had a trading volume of 503,631 shares, compared to its average volume of 1,220,515. Grail, Inc. has a 1-year low of $12.33 and a 1-year high of $63.99. The business's 50-day simple moving average is $29.54 and its 200 day simple moving average is $25.87.

Grail (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating analysts' consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analyst estimates of $35.33 million. As a group, equities analysts predict that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Insider Buying and Selling at Grail

In other news, CEO Robert P. Ragusa sold 7,625 shares of Grail stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.21, for a total transaction of $237,976.25. Following the sale, the chief executive officer now owns 828,662 shares in the company, valued at approximately $25,862,541.02. The trade was a 0.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $65,800.80. Following the sale, the president now owns 559,673 shares in the company, valued at $17,461,797.60. This trade represents a 0.38% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 194,948 shares of company stock worth $6,583,130 over the last ninety days. Corporate insiders own 1.85% of the company's stock.

Analyst Ratings Changes

Several research firms have recently commented on GRAL. Morgan Stanley raised their price target on Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Tuesday, March 18th. Canaccord Genuity Group began coverage on Grail in a research report on Monday, April 21st. They set a "buy" rating and a $32.00 price target for the company.

Grail Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.